Science | Nature | Cell | View More
Natural Products
Dasatinib monohydrate
Dasatinib monohydrate
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Dasatinib monohydrate
Price:
CAS No.: 863127-77-9
Catalog No.: CFN90015
Molecular Formula: C22H28ClN7O3S
Molecular Weight: 506.02 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source:
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Download: COA    MSDS
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Instytut Nawozów Sztucznych w ... (Poland)
  • University of Limpopo (South Africa)
  • University of Vienna (Austria)
  • Universita' Degli Studi Di Cagl... (Italy)
  • University Medical Center Mainz (Germany)
  • University of Padjajaran (Indonesia)
  • Helmholtz Zentrum München (Germany)
  • Aveiro University (Portugal)
  • Johannes Gutenberg University M... (Germany)
  • Celltrion Chemical Research Ins... (Korea)
  • Seoul National University (Korea)
  • More...
Package
Featured Products
Genkwanin

Catalog No: CFN98670
CAS No: 437-64-9
Price: $60/20mg
Strychnine

Catalog No: CFN98130
CAS No: 57-24-9
Price: $60/20mg
D-(-)-Quinic acid

Catalog No: CFN99930
CAS No: 77-95-2
Price: $30/20mg
Ginsenoside Compound K

Catalog No: CFN99756
CAS No: 39262-14-1
Price: $30/20mg
8-Gingerol

Catalog No: CFN99131
CAS No: 23513-08-8
Price: $118/20mg
Trametenolic acid

Catalog No: CFN92366
CAS No: 24160-36-9
Price: $318/10mg
Cannabigerol

Catalog No: CFN98287
CAS No: 25654-31-3
Price: $338/10mg
Calceolarioside B

Catalog No: CFN90647
CAS No: 105471-98-5
Price: $238/20mg
Phloretin

Catalog No: CFN97040
CAS No: 60-82-2
Price: $40/20mg
Parishin C

Catalog No: CFN93114
CAS No: 174972-80-6
Price: $238/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Dasatinib monohydrate is a selective protein tyrosine kinase inhibitor with immunomodulatory properties that abrogates multiple signal transduction pathways in immune cells, it may be used to treat multiple sclerosis. Dasatinib is a 2-aminothiazole-derived inhibitor of Src family kinases, inhibits c-Abl and Bcr-Abl tyrosine kinase activity and shows efficacy against imatinib-resistant Bcr-Abl mutations. Combined treatment with bortezomib plus Dasatinib monohydrate caused cell cycle arrest in the G1 phase through inactivation of PDGFRβ and promoted bortezomib-induced apoptosis in GIST-T1 cells. Dasatinib monohydrate monotherapy demonstrates anti‑ovarian cancer activities. The effects of Dasatinib monohydrate and paclitaxel treatments on ovarian cancer cells appeared to be mediated by the Src pathway.
Targets: TNF-α | NO | MMP(e.g.TIMP) | IL Receptor | LTR | Bcr-Abl | Src
In vitro:
Biochem J. 2015 Jan 15;465(2):271-9.
The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases.[Pubmed: 25351958]
We demonstrate that the clinically approved cancer drugs bosutinib and Dasatinib monohydrate induce several hallmark features of 'regulatory'-like macrophages.
METHODS AND RESULTS:
Treatment of macrophages with bosutinib or Dasatinib monohydrate elevates the production of IL-10 while suppressing the production of IL-6, IL-12p40 and tumour necrosis factor α (TNFα) in response to Toll-like receptor (TLR) stimulation. Moreover, macrophages treated with bosutinib or Dasatinib monohydrate express higher levels of markers of 'regulatory'-like macrophages including LIGHT, SPHK1 and arginase 1. Bosutinib and Dasatinib monohydrate were originally developed as inhibitors of the protein tyrosine kinases Bcr-Abl and Src but we show that, surprisingly, the effects of bosutinib and Dasatinib monohydrate on macrophage polarization are the result of the inhibition of the salt-inducible kinases. Consistent with the present finding, bosutinib and Dasatinib monohydrate induce the dephosphorylation of CREB-regulated transcription co-activator 3 (CRTC3) and its nuclear translocation where it induces a cAMP-response-element-binding protein (CREB)-dependent gene transcription programme including that of IL-10. Importantly, these effects of bosutinib and Dasatinib monohydrate on IL-10 gene expression are lost in macrophages expressing a drug-resistant mutant of salt-inducible kinase 2 (SIK2).
CONCLUSIONS:
In conclusion, our study identifies the salt-inducible kinases as major targets of bosutinib and Dasatinib monohydrate that mediate the effects of these drugs on the innate immune system and provides novel mechanistic insights into the anti-inflammatory properties of these drugs.
Mol Med Rep. 2015 Sep;12(3):3249-56.
Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.[Pubmed: 25975261]
The potential effect of Dasatinib monohydrate on ovarian cancer is not clear. The aim of the present study was to investigate the antitumor activity of Dasatinib monohydrate, alone and in combination with paclitaxel, in ovarian cancer in vitro and in vivo.
METHODS AND RESULTS:
In the present study, the expression of Src and phospho‑Src-Y416 (p‑Src) was measured in six ovarian cancer cell lines using western blotting and immunohistochemistry. In addition, cell viability and apoptosis were measured using an MTT assay and annexin V‑fluorescein isothiocyanate staining. An ovarian cancer murine xenograft model was established, in order to evaluate the antitumor effect of Dasatinib monohydrate alone and in combination with paclitaxel in ovarian cancer. High levels of p‑Src protein expression were observed in all cell lines, as compared with healthy cells, which indicated activation of the Src signaling pathway. p‑Src expression increased in ovarian cancer cells following paclitaxel treatment. Dasatinib monohydrate treatment demonstrated anti‑ovarian cancer properties, by downregulating p‑Src expression and by inducing cancer cell apoptosis. Combined treatment with Dasatinib monohydrate and paclitaxel markedly inhibited proliferation and promoted apoptosis of ovarian cancer cells, compared with control cells. Combined Dasatinib monohydrate and paclitaxel treatment exhibited antitumor activities in vivo and in vitro (combination indices, 0.25‑0.93 and 0.31‑0.75; and tumor growth inhibitory rates, 76.7% and 58.5%, in A2780 and HO8910 cell lines, respectively), compared with paclitaxel treatment alone.
CONCLUSIONS:
Dasatinib monohydrate monotherapy demonstrated anti‑ovarian cancer activities. The effects of Dasatinib monohydrate and paclitaxel treatments on ovarian cancer cells appeared to be mediated by the Src pathway.
Dasatinib monohydrate Description
Source:
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Licoflavanone

Catalog No: CFN95213
CAS No: 119240-82-3
Price: $413/5mg
2-O-cinnamoyl-beta-D-glucose

Catalog No: CFN95111
CAS No: N/A
Price: $218/5mg
3'-Hydroxy-5,7,4',5'-Tetramethoxyf...

Catalog No: CFN95397
CAS No: 29976-51-0
Price: $318/5mg
Indolelactic acid

Catalog No: CFN95263
CAS No: 1821-52-9
Price: $100/20mg
Apigenin-8-C-beta-D-glucopyranosyl...

Catalog No: CFN95548
CAS No: N/A
Price: $368/5mg
1,3,6-Trihydroxy-2-methylanthraqui...

Catalog No: CFN95095
CAS No: 87686-87-1
Price: $218/10mg
3'-Hydroxy-5,7,4'-trimethoxyflavon...

Catalog No: CFN95396
CAS No: 33554-52-8
Price: $318/5mg
Oblonganoside D

Catalog No: CFN95460
CAS No: 943021-91-8
Price: $318/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9762 mL 9.881 mL 19.7621 mL 39.5241 mL 49.4052 mL
5 mM 0.3952 mL 1.9762 mL 3.9524 mL 7.9048 mL 9.881 mL
10 mM 0.1976 mL 0.9881 mL 1.9762 mL 3.9524 mL 4.9405 mL
50 mM 0.0395 mL 0.1976 mL 0.3952 mL 0.7905 mL 0.9881 mL
100 mM 0.0198 mL 0.0988 mL 0.1976 mL 0.3952 mL 0.4941 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Cancer Lett. 2015 May 28;361(1):137-46.
Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells.[Pubmed: 25737303]
Dasatinib monohydrate-based therapy is often used as a second-line therapeutic strategy for imatinib-resistance gastrointestinal stromal tumors (GISTs); however, acquired aberrant activation of Dasatinib monohydrate target proteins, such as c-KIT and PDGFRβ, attenuates the therapeutic efficiency of Dasatinib monohydrate.
METHODS AND RESULTS:
Combination therapy which inhibits the activation of Dasatinib monohydrate target proteins may enhance the cytotoxicity of Dasatinib monohydrate in GISTs. Bortezomib, a proteasome inhibitor, significantly inhibited cell viability and promoted apoptosis of Dasatinib monohydrate-treated GIST-T1 cells, whereas GIST-T1 cells showed little Dasatinib monohydrate cytotoxicity when treated with Dasatinib monohydrate alone, as the upregulation of c-KIT caused by Dasatinib monohydrate itself interfered with the inhibition of c-KIT and PDGFRβ phosphorylation by dasatinib. Bortezomib induced internalization and degradation of c-KIT by binding c-KIT to Cbl, an E3 ubiquitin-protein ligase, and the subsequent release of Apaf-1, which was originally bound to the c-KIT-Hsp90β-Apaf-1 complex, induced primary apoptosis in GIST-T1 cells. Combined treatment with bortezomib plus Dasatinib monohydrate caused cell cycle arrest in the G1 phase through inactivation of PDGFRβ and promoted bortezomib-induced apoptosis in GIST-T1 cells.
CONCLUSIONS:
Our data suggest that combination therapy exerts better efficiency for eradicating GIST cells and may be a promising strategy for the future treatment of GISTs.
Animal Research:
Immunopharmacol Immunotoxicol. 2015 Jun;37(3):287-94.
Therapeutic effects of dasatinib in mouse model of multiple sclerosis.[Pubmed: 25975582]
Dasatinib monohydrate (Sprycel) is a selective protein tyrosine kinase inhibitor with immunomodulatory properties that abrogates multiple signal transduction pathways in immune cells. In the present research, our aim was to test the therapeutic efficacy of Dasatinib monohydrate in experimental model of MS.
METHODS AND RESULTS:
We performed EAE induction in female C57BL/6 mice by myelin oligodendrocyte glycoprotein35-55 (MOG35-55) in Complete Freund's Adjuvant (CFA) emulsion, and used Dasatinib monohydrate for the treatment of EAE. During the course of study, clinical evaluation was assessed, and on day 21 post-immunization blood samples were taken from the heart of mice for tumor necrosis factor-alpha (TNF-α), nitric oxide (NO) and antioxidants capacity evaluation. The mice were sacrificed and brains and cerebellums of mice were removed for histological analysis. Also for in vitro analysis, we used C6 astrocytoma cell line to evaluate the inhibitory effects of Dasatinib monohydrate in cell proliferation and matrix metalloproteinase-2 (MMP-2) activity. Our findings demonstrated that Dasatinib monohydrate had beneficial effects on EAE by lower incidence, attenuation in the severity and a delay in the onset of disease. The serum level of NO and TNF-α in Dasatinib monohydrate treated mice was significantly lower than control mice. In vitro, Dasatinib monohydrate inhibited cell proliferation and MMP-2 activity.
CONCLUSIONS:
Dasatinib monohydrate with its potential therapeutic effects and immunomodulatory properties may be recommended, after additional necessary tests and trials, for the treatment of MS.
Genkwanin

Catalog No: CFN98670
CAS No: 437-64-9
Price: $60/20mg
Strychnine

Catalog No: CFN98130
CAS No: 57-24-9
Price: $60/20mg
D-(-)-Quinic acid

Catalog No: CFN99930
CAS No: 77-95-2
Price: $30/20mg
Ginsenoside Compound K

Catalog No: CFN99756
CAS No: 39262-14-1
Price: $30/20mg
8-Gingerol

Catalog No: CFN99131
CAS No: 23513-08-8
Price: $118/20mg
Trametenolic acid

Catalog No: CFN92366
CAS No: 24160-36-9
Price: $318/10mg
Cannabigerol

Catalog No: CFN98287
CAS No: 25654-31-3
Price: $338/10mg
Calceolarioside B

Catalog No: CFN90647
CAS No: 105471-98-5
Price: $238/20mg
Phloretin

Catalog No: CFN97040
CAS No: 60-82-2
Price: $40/20mg
Parishin C

Catalog No: CFN93114
CAS No: 174972-80-6
Price: $238/20mg
Tags: buy Dasatinib monohydrate | Dasatinib monohydrate supplier | purchase Dasatinib monohydrate | Dasatinib monohydrate cost | Dasatinib monohydrate manufacturer | order Dasatinib monohydrate | Dasatinib monohydrate distributor